FC — Franklin Covey Co. · 2026-09-05 · Verdict: WATCH · Conviction 3

Price $19.02 (screen row, 2026-09-05 run of universe_under2b.csv; no live quote available) · Mkt cap $214.8M · EV $202.8M · EV/EBIT 35.6x on the screen's stale CY2025 EBIT, about 13.9x on FY26 guided clean EBIT · FCF yield 9.6% as screened, about 5.6% on the company's own FY25 free cash flow · Net cash $12.0M · ADV $1.33M Sources read: 10-K 2025-11-12 for FY ended 2025-08-31 (Items 1, 1A, 7), 10-Q 2026-07-07 (quarter ended 2026-05-31), DEF 14A 2025-12-18, 8-Ks 2026-04-01, 2026-07-01 and 2026-09-01, Form 4s (12m). No transcript was in the bundle; quotes are from the EX-99.1 earnings releases.

1. What the business actually does

Franklin Covey sells leadership and organizational performance content on subscription. Enterprise (North America plus International) sells the All Access Pass, giving corporate clients the 7 Habits, 4 Disciplines of Execution, Speed of Trust and Multipliers content plus consultants and coaches; Education sells the Leader in Me membership, in use at over 8,000 schools. FY2025 revenue was $267.1M, of which $225.9M was subscription and subscription services, at a 76.2% gross margin, with no client over 10% of revenue (10-K 2025, Items 1 and 7). The fiscal year ends August 31.

2. Why it is mispriced — the edge case

There is no forced seller and no discrete edge case, so the verdict is capped at WATCH. What is real is that the screen's 35.6x EV/EBIT is an artifact: trailing GAAP EBIT of $5.7M absorbed $6.7M of FY25 restructuring and $2.1M of campus exit costs (10-K 2025, Item 7), and the first three quarters of FY26 absorbed $5.65M more of restructuring plus $1.27M of building exit costs (8-K 2026-07-01, EX-99.1). Against the FY26 guide of $28M to $31M of Adjusted EBITDA, the same $202.8M enterprise value is 6.9x.

The only structural feature is neglect: 11.3M shares and $1.33M of daily volume make this untouchable for most institutions. But neglect is a permanent condition, not a catalyst, and the market has already re-rated the name: the stock is up 54.1% over six months and sits only 25.6% below its 52-week high (universe_under2b.csv). Someone has already paid for the restructuring being over.

3. Unit economics and growth

Invoiced amounts, the metric management points to, have turned: Enterprise North America invoiced amounts grew 7%, 7% and 4% in the first three quarters of FY26, or 6% year to date to $114.3M, and consolidated deferred revenue rose 7% to $96.0M (8-Ks 2026-04-01 and 2026-07-01, EX-99.1).

Two corrections cut against that. Unbilled deferred revenue, contracted but off balance sheet, fell to $61.1M from $62.0M, so the total contracted book is $157.1M against $151.3M, growth of 3.8%: part of the invoiced growth is a shift from unbilled to billed, not new business. And the growth arriving is the lower-margin half of the mix. North America service and product revenue grew 9% to $15.4M in Q3 while subscription revenue fell 2% to $22.0M, and consolidated gross margin fell to 73.9% from 76.5%, North America to 79.5% from 82.9% and Education to 62.8% from 65.6% (10-Q 2026-07-07, Item 2).

Profit remains far below its own history: Adjusted EBITDA ran $28.0M, $42.2M, $48.1M, $55.3M and $28.8M in FY2021 through FY2025 (DEF 14A 2025-12-18, pay-versus-performance table), and FY26 is guided flat to that trough. Education is now the weak division, at $1.166M of nine-month Adjusted EBITDA against $2.006M after a state cut a statewide Leader in Me contract. Free cash flow is thinner than screened because the screen ignores capitalized curriculum: FY25 operating cash flow of $29.0M less $16.9M of investing left about $12.1M (10-K 2025, Item 7).

4. Balance sheet and capital allocation

Clean. At 2026-05-31: $12.0M cash, no notes payable, the full $62.5M revolver undrawn, $74.5M of liquidity. The 2023 KeyBank agreement matures 2028-03-27 and requires leverage under 3.00x and fixed charge coverage over 1.15x, permitting buybacks only while compliant (10-Q 2026-07-07).

Buybacks have been aggressive and well priced: $26.4M in FY25 and $28.1M in nine months of FY26, including 947,000 shares for $17.0M in Q2 at about $17.95, below today's price. Diluted shares fell from 12,891k to 11,451k year over year on a $50.0M authorization replenished 2025-08-11, though cash fell from $48.7M to $31.7M to $12.0M funding it and the revolver was drawn intra-quarter in Q2. Insiders own a lot but bought none: twelve months hold zero open-market purchases, five grants, five tax-withholding dispositions and three gifts, including 31,092 shares given away by director and former CEO Robert Whitman, who still holds 681,719 (form4_last12m.csv).

5. Management: what they said versus what they did

Pay genuinely flexed with results: FY25 STIP paid CEO Paul Walker $15,245 against a $585,000 target and compensation actually paid to him was negative $1,364,744, against five-year TSR of $99.09 versus $148.37 for the peer index (DEF 14A 2025-12-18). Guidance is the blemish. On 2026-04-01 the CFO said "we are reaffirming our FY2026 guidance of total revenue of $265 to $275 million and Adjusted EBITDA of $28 to $33 million." Thirteen weeks later revenue was cut to $260M to $267M and EBITDA narrowed to $28M to $31M (8-K 2026-07-01, EX-99.1).

6. Valuation

Guided FY26 Adjusted EBITDA of $29.5M at the midpoint, less roughly $4.5M of depreciation, $3.0M of intangible amortization and $7.4M of stock compensation, is about $14.6M of clean EBIT, so the $202.8M enterprise value is about 13.9x. Bear: the invoiced growth was a billed/unbilled shift and margin keeps eroding, FY27 revenue flat at $263M on a 10% margin for $26M at 6x, about $15. Base: revenue recovers to $275M at a 13.5% margin for $37M at 7.5x, about $27. Bull: the transformation converts, $285M at 16% for $45.6M at 9x, about $40. Weighting 30/50/20 gives $26.05, roughly 37% above price. Reverse DCF: at $19.02 the price implies about 6.9% perpetual growth in after-tax owner earnings of roughly $6.2M (guided Adjusted EBITDA less stock compensation, $13M of capex and interest, taxed at 30%) at a 10% discount rate, or 4.4% if stock compensation is not charged.

7. Catalysts and timeline

FY26 ended 2026-08-31 and results should arrive in early November (the FY25 10-K was filed 2025-11-12). That print carries the seasonally largest quarter, tests the revised guide, and brings the first FY27 guidance, which management has repeatedly said will show growth in revenue, Adjusted EBITDA and free cash flow. Secondary: restoration of the state education funding, and continued repurchases.

8. Risks and pre-registered kill criteria

Risks: the guide was cut once already this year; Education depends on state and federal budgets; direct offices in China, Japan and the UK are still shrinking; the 10-K names AI as a force that could reduce demand for its products (10-K 2025, Item 1A). Kill criteria: 1. Enterprise North America invoiced amounts grow less than 3% year over year in two consecutive quarters. 2. Consolidated gross margin below 74.0% in two consecutive quarters. 3. FY27 Adjusted EBITDA guided below $32M, meaning no growth off the FY26 range. 4. Deferred revenue plus unbilled deferred revenue declines year over year at any quarter end.

9. Verdict and summary

WATCH, conviction 3. Franklin Covey is a debt-free, 76% gross margin subscription business whose 35.6x screen multiple is a real artifact of $6.7M of FY25 restructuring and $6.9M more in FY26, and the operating turn is visible: three straight quarters of Enterprise North America invoiced growth and a share count down 10.7%, bought below today's price. But there is no edge case to underwrite, no forced seller, spin or index event, and the stock has already risen 54% in six months to sit 26% below its high, so the artifact has largely been paid for. The cheapness is overstated too: the 9.6% FCF yield ignores $6M to $8M a year of capitalized curriculum and is nearer 5.6%, and after stock compensation the price is about 13.9x clean EBIT, not cheap for a company guiding revenue down again. Two facts decide it: the invoiced growth is partly a shift from unbilled to billed, since the total contracted book grew only 3.8%, and what is growing is lower-margin services while gross margin fell 260 basis points, alongside a guide cut thirteen weeks after reaffirmation and no insider buying at any price in twelve months. Probability-weighted value near $26 is 37% above price, but the number that settles it is the fiscal fourth quarter, closed 2026-08-31 and not yet reported.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.